Regulatory Scrutiny and Compliance Failures: Operating in highly regulated life sciences and diagnostics markets, Revvity faces risks from evolving regulations, non-compliance fines, product recalls, or market withdrawal if products do not meet safety or efficacy standards.

Intense Market Competition and Pricing Pressure: The company competes with numerous established players and agile startups, leading to potential loss of market share, pricing pressures, and the need for continuous innovation to maintain competitive advantage.

Dependence on Successful Research and Development: Revvity's future growth relies on its ability to successfully develop, commercialize, and gain market acceptance for new products and technologies. Failure to innovate or keep pace with technological advancements could harm its business.